HCPCS codes / Q / Q2056
Q2056
Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Code type
- HCPCS Level II
- Coverage
- Carrier judgment
- BETOS category
- O1D
- Pricing indicator
- 51
- Effective date
- 20221001
Verify before billing. Confirm against current official CMS HCPCS files and your payer's rules before clinical or claims use.